Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of life Pythia T Nieuwkerk, Petra J Hajenius, M.D., Willem M Ankum, M.D., Ph.D., Fulco Van der Veen, M.D., Ph.D., Wouter Wijker, Ph.D., Patrick M.M Bossuyt, Ph.D. Fertility and Sterility Volume 70, Issue 3, Pages 511-517 (September 1998) DOI: 10.1016/S0015-0282(98)00212-X
FIGURE 1 Physical functioning (A), role functioning (B), social functioning (C), and pain (D) in patients who received systemic methotrexate therapy versus laparoscopic salpingostomy (means ± SEs). • = systemic methotrexate; ♢ = laparoscopic salpingostomy. Fertility and Sterility 1998 70, 511-517DOI: (10.1016/S0015-0282(98)00212-X)